Literature DB >> 23788587

Bupropion diversion and misuse in the correctional facility.

Wanda T Hilliard1, Linda Barloon, Philip Farley, Joseph V Penn, Angela Koranek.   

Abstract

The antidepressant bupropion plays an important role in the treatment of mental health disorders. It is well known that incarcerated individuals are at increased risk of experimenting with psychiatric medications and it is imperative for prescribers and clinicians to understand the misuse potential of these medications, including bupropion. The mechanism of reinforcement of misuse of bupropion is related to the effect on dopamine and norepinephrine neurotransmitter systems. When bupropion is crushed and ingested via nasal insufflation, a faster and higher affinity for neurotransmitters occurs, heightening the misuse potential. A literature search and illustrative case studies are presented demonstrating the misuse potential, along with a review of the clinical implications. This article concludes that in the incarcerated population, bupropion is a medication with significant misuse and diversion potential.

Entities:  

Keywords:  bupropion; correctional facility; diversion; nasal insufflation; substance abuse

Mesh:

Substances:

Year:  2013        PMID: 23788587     DOI: 10.1177/1078345813486448

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  12 in total

1.  [Intravenous abuse of bupropione].

Authors:  N Behler; A Lehmann; B Malchow; U Palm
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

2.  Approved and Off-Label Use of Prescribed Psychotropic Medications among Federal Canadian Inmates.

Authors:  Gregory P Brown; Lynn A Stewart; Terry Rabinowitz; Harold Boudreau; Angela J Wright
Journal:  Can J Psychiatry       Date:  2018-04-29       Impact factor: 4.356

3.  Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release.

Authors:  Abdelrahman R Shalabi; Donna Walther; Michael H Baumann; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2017-02-27       Impact factor: 4.418

4.  Rates of Anomalous Bupropion Prescriptions in Ontario, Canada.

Authors:  Leah S Steele; Erin M Macdonald; Tara Gomes; Simon Hollands; J Michael Paterson; Muhammad M Mamdani; David N Juurlink
Journal:  Ann Fam Med       Date:  2015 Jul-Aug       Impact factor: 5.166

Review 5.  Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Wim Verbeeck; Geertruida E Bekkering; Wim Van den Noortgate; Cornelis Kramers
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

Review 6.  Abuse and misuse of antidepressants.

Authors:  Elizabeth A Evans; Maria A Sullivan
Journal:  Subst Abuse Rehabil       Date:  2014-08-14

7.  Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Authors:  Laurie S Anderson; Heidi G Bell; Michael Gilbert; Julie E Davidson; Christina Winter; Monica J Barratt; Beta Win; Jeffery L Painter; Christopher Menone; Jonathan Sayegh; Nabarun Dasgupta
Journal:  JMIR Public Health Surveill       Date:  2017-02-01

8.  Possible addiction transference from cocaine insufflation to oral bupropion in bipolar patient.

Authors:  Carolina Costa; Alberto Araujo; Marco Brasil; Marcelo Cruz
Journal:  J Addict Med       Date:  2015 Mar-Apr       Impact factor: 3.702

9.  Stimulants for the Control of Hedonic Appetite.

Authors:  Alison S Poulton; Emily J Hibbert; Bernard L Champion; Ralph K H Nanan
Journal:  Front Pharmacol       Date:  2016-04-25       Impact factor: 5.810

10.  Is There a Potential of Misuse for Venlafaxine and Bupropion?

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  Front Pharmacol       Date:  2018-03-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.